Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
4.860
-0.090 (-1.82%)
At close: Mar 18, 2026, 4:00 PM EDT
4.860
0.00 (0.00%)
After-hours: Mar 18, 2026, 4:23 PM EDT
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts that cover Perspective Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $12, which forecasts a 146.91% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $16.
Price Target: $12 (+146.91%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Buy | 5 | 3 | 3 | 3 | 4 | 3 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +167.49% | Mar 18, 2026 |
| UBS | UBS | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +64.61% | Mar 18, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +126.34% | Mar 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $18 → $14 | Buy | Maintains | $18 → $14 | +188.07% | Mar 17, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +188.07% | Mar 17, 2026 |
Financial Forecast
Revenue This Year
996.34K
from 884.00K
Increased by 12.71%
Revenue Next Year
765.13K
from 996.34K
Decreased by -23.21%
EPS This Year
-1.28
from -1.40
EPS Next Year
-1.13
from -1.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.5M | 1.5M | |||
| Avg | 996,336 | 765,133 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 66.3% | 47.5% | |||
| Avg | 12.7% | -23.2% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.04 | -0.69 | |||
| Avg | -1.28 | -1.13 | |||
| Low | -1.94 | -1.47 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.